| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/22/2004 | US20040077048 Used in the diagnosis, treatment, and prevention of gastrointestinal, cardiovascular, autoimmune/ inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 04/22/2004 | US20040077045 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 04/22/2004 | US20040077042 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 04/22/2004 | US20040077022 Modified peptides as therapeutic agents |
| 04/22/2004 | US20040077011 Novel human gene relating to respiratory diseases and obesity |
| 04/22/2004 | US20040077009 Human cyclin-dependent kinase (hPNQALRE) |
| 04/22/2004 | US20040077007 Human SMN-like protein |
| 04/22/2004 | US20040077002 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty; atherosclerosis |
| 04/22/2004 | US20040076997 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18 |
| 04/22/2004 | US20040076991 Modified interleukin-1 receptor antagonist(il-1ra) with reduced immunogenicity |
| 04/22/2004 | US20040076986 A gene and/or a protein involved in the prevention or treatment of allergic diseases and dermatitis |
| 04/22/2004 | US20040076973 Oligonucleotide targeted to a nucleic acid molecule encoding ubiquitin protein ligase WWP1 or WWP2; hybridizes with and inhibits the expression of the ubiquitin protein ligase. |
| 04/22/2004 | US20040076967 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/22/2004 | US20040076965 MIA-2 protein |
| 04/22/2004 | US20040076949 Methods for identifying inhibitors of helicase activity from hepatitis C virus |
| 04/22/2004 | US20040076672 For treating cancer and other angiogenic-dependent diseases, and more specifically, to compositions comprising anti-angiogenic factors and polymeric carriers, stents which have been coated with such compositions |
| 04/22/2004 | US20040076645 Ghrelin-carrier conjugates |
| 04/22/2004 | US20040076643 HIV-encoded chemoattractant |
| 04/22/2004 | US20040076637 A synthetic peptide comprising an amino acid sequence from the viral glycoprotein 41, a hydrophobic domain, for preventing HIV fusion to a target cell |
| 04/22/2004 | US20040076631 Treating infections caused by respiratory syncytial virus, transfected eukaryotic cells, isolating human B cells from transfected mouse, use for immunoassay, diagnosis the virus, test kits |
| 04/22/2004 | US20040076629 Polypeptide with 46 kDalton HMFG differentiation antigen binding specificity and clotting factors V and VIII light-chain homologies, fusion protein, polynucleotide and polyribonucleotide encoding the polypeptide, anti-polypeptide antibodies, kits and methods of use thereof |
| 04/22/2004 | US20040076628 Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076626 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 04/22/2004 | US20040076624 Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections |
| 04/22/2004 | US20040076622 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| 04/22/2004 | US20040076621 An oligo- or poly-nucleotides is used to inhibit gene expression of antigen, therapeutic treatment of leukemia, atherosclerosis cardiovascular disorders |
| 04/22/2004 | US20040076619 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 04/22/2004 | US20040076616 A lytic enzyme is produced by a bacteria being infected with a bacteriophage specific |
| 04/22/2004 | US20040076614 For natural cellular immune defense in humans/animals; for foods/feeds |
| 04/22/2004 | US20040076613 Vector system |
| 04/22/2004 | US20040076610 Method of treating portal hypertension |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/22/2004 | US20040076606 Methods of modulating inflammation by administration of interleukin-19 and inhibitors of IL-19 binding |
| 04/22/2004 | US20040076605 Method of regenerating human tissue |
| 04/22/2004 | US20040076599 Keratin-based powders and hydrogel for pharmaceutical applications |
| 04/22/2004 | US20040076589 Comprises albuterol/insulin; eliminates need for injections |
| 04/22/2004 | US20040076587 Such as 1-(N2-(3,5-dibromo-N-((4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1 -piperidinyl)carbonyl)-D-tyrosyl)-L-lysyl)-4-(4-pyridinyl)-piperazine; calcitonin gene related peptide (CGRP) |
| 04/22/2004 | US20040074504 Method and composition for inhibiting cardiovascular cell proliferation |
| 04/22/2004 | CA2782847A1 Methods of administering fgf18 |
| 04/22/2004 | CA2502304A1 Phenolic binding peptides |
| 04/22/2004 | CA2501941A1 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 04/22/2004 | CA2501940A1 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use |
| 04/22/2004 | CA2501926A1 A method for determining the susceptibility of a subject to oral infection by the detection of ll-37 |
| 04/22/2004 | CA2501913A1 Isolated mammalian membrane protein genes; related reagents |
| 04/22/2004 | CA2501875A1 Cap-binding protein |
| 04/22/2004 | CA2501807A1 Treatment of allergic conditions by use of il 21 |
| 04/22/2004 | CA2501685A1 Compounds for modulation of cholesterol transport |
| 04/22/2004 | CA2501630A1 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | CA2501577A1 Heat shock protein binding fragments of cd91, and uses thereof |
| 04/22/2004 | CA2501459A1 Production of homotrimeric fusion proteins |
| 04/22/2004 | CA2501238A1 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| 04/22/2004 | CA2501133A1 Oral formulations for proteins and polypeptides |
| 04/22/2004 | CA2501057A1 Igf-binding protein-derived peptide or small molecule |
| 04/22/2004 | CA2500772A1 Uses of human zven antagonists |
| 04/22/2004 | CA2500742A1 Compositions of fgf-18 and hyaluronic acid for stimulating cartilage production and treating osteoarthritis |
| 04/22/2004 | CA2500665A1 Methods of regulating body weight |
| 04/22/2004 | CA2500592A1 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | CA2500587A1 Screening and therapeutic methods relating to neurogenesis |
| 04/22/2004 | CA2500577A1 The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine |
| 04/22/2004 | CA2499896A1 Hepatocyte growth factor variants |
| 04/22/2004 | CA2487854A1 Method for screening an agent for treating renal failure |
| 04/22/2004 | CA2445364A1 Method for producing fish gelatin peptide |
| 04/21/2004 | EP1411128A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1411063A1 Peptide nucleic acids |
| 04/21/2004 | EP1411061A1 Poly-alpha2,8-sialic acid mimetic peptides and their application |
| 04/21/2004 | EP1410807A1 Methods and compositions useful for inhibition of angiogenesis |
| 04/21/2004 | EP1410803A1 MIA-2 proteins |
| 04/21/2004 | EP1410802A1 Cell death inducers for mast cells |
| 04/21/2004 | EP1410801A1 Method for promoting hematopoietic cell proliferation and differentiation |
| 04/21/2004 | EP1410798A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 04/21/2004 | EP1410040A2 Method for identifying substances which modulate interleukin 4 (il-4) signaling |
| 04/21/2004 | EP1410038A2 Assays for identifying modulators of rhomboid polypeptides |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409748A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 04/21/2004 | EP1409740A2 Asthma-associated gene |
| 04/21/2004 | EP1409734A2 Diagnosis and treatment of cancer |
| 04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409694A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 04/21/2004 | EP1409692A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 04/21/2004 | EP1409690A2 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 04/21/2004 | EP1409687A2 22244 and 8701, human dehydrogenases and uses thereof |
| 04/21/2004 | EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF |
| 04/21/2004 | EP1409682A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409679A2 Nov-x proteins and nucleic acids encoding same |
| 04/21/2004 | EP1409678A2 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep) |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409676A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 04/21/2004 | EP1409675A1 Gene involved in apoptosis regulation |
| 04/21/2004 | EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 04/21/2004 | EP1409672A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 04/21/2004 | EP1409670A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 04/21/2004 | EP1409668A2 Antisense nucleic acid against alphav integrin |
| 04/21/2004 | EP1409661A2 Hdac9 polypeptides and polynucleotides and uses thereof |
| 04/21/2004 | EP1409660A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
| 04/21/2004 | EP1409658A2 Aggrecanase molecules |